-
Sector Analysis
NewMultiple Myeloma Epidemiology Analysis and Forecast to 2032
Multiple Myeloma Vaccines Report Overview In the 8MM, there were 80,305 diagnosed incident cases of multiple myeloma vaccines in 2022. The diagnosed incident cases of multiple myeloma vaccines are expected to register an AGR of more than 1% during 2022-2032. Multiple myeloma (MM) is a hematologic cancer that forms in a type of white blood cell called plasma cells. Normal plasma cells help fight infections by making antibodies that recognize and attack germs, but MM causes cancer cells to accumulate...
-
Product Insights
Multiple Myeloma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Multiple Myeloma Clinical Trial Market Overview The Multiple Myeloma (Kahler Disease) clinical trial market research report provides an overview of Multiple Myeloma (Kahler Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Myeloma (Kahler Disease). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Sector Analysis
Multiple Myeloma – Cell Therapies 15-Market Assessment and Sales Forecast to 2031
Explore in-depth market insights from the following data in our ‘Multiple Myeloma Cell Therapy Market’ report: Access updated epidemiology for patient populations relevant to cell therapy in 2021-2031 Review updated prescription habits at the class level for already established therapies (defined in our analysis as chemotherapy, targeted therapies, and others [such as immune checkpoint inhibitors or hormone therapies]) and compare their future projections to cell therapy pipeline drugs Full market assessment in the 8MM of all currently marketed and late-stage pipeline cell therapy drugs with drug-level forecasts, supplemented by class-level forecasts for early-stage molecules Explore indication-specific top-line sales forecasts across 15 countries, in the 8MM and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.